Results of new research showing that COVID-19 mRNA-based vaccines seemingly boosted immunity in cancer patients and prolonged their lives are preliminary, stemming from a retrospective examination of cancer patients’ records. The next step is to validate the findings [in a randomized clinical trial now being designed.

Subscribe to continue reading this article.

Already subscribed? To log in, click here.

See Full Page